Para-Cresol and the Brain: Emerging Role in Neurodevelopmental and Neurodegenerative Disorders and Therapeutic Perspectives
Open Access
- 15 September 2025
- journal article
- review article
- Published by American Chemical Society (ACS) in ACS Pharmacology & Translational Science
- Vol. 8 (10) , 3432-3452
Abstract
p-Cresol (pC) is a phenolic compound to which humans can be exposed through both environmental sources, such as a pollutant, and endogenous production by the gut microbiota. Among microbial contributors, Clostridioides difficile appears to be a major source of pC within the body. Once absorbed, pC is highly protein-bound in plasma and predominantly circulates in its hepatic conjugated forms: p-cresyl sulfate (pCS) and p-cresol glucuronide (pCG), which are mainly excreted in urine. Accumulation of these metabolites, particularly pCS, classified as a protein-bound uremic toxin, has been associated with the progression of chronic kidney disease (CKD) and related complications, due to its pro-oxidant, pro-inflammatory, and pro-apoptotic properties. CKD patients are at increased risk for cognitive impairment, affective disorders, and central nervous system (CNS) dysfunctions. In recent years, increasing evidence has suggested a potential role of pC and its metabolites in CNS diseases. Here, we summarize current knowledge on the involvement of these compounds in the pathogenesis and progression of autism spectrum disorder, Parkinson's disease, Alzheimer's disease, and post-traumatic stress disorder. We also discuss how modulating systemic levels of pC may represent a promising strategy to improve pathological phenotypes in the context of neurodevelopmental and neurodegenerative disorders.Keywords
This publication has 206 references indexed in Scilit:
- Gut mobilization improves behavioral symptoms and modulates urinary p‐cresol in chronically constipated autistic children: A prospective studyAutism Research, 2021
- Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's DiseaseMovement Disorders, 2020
- Unraveling gut microbiota in Parkinson's disease and atypical parkinsonismMovement Disorders, 2018
- Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiomeMovement Disorders, 2017
- Slow intestinal transit contributes to elevate urinary p‐cresol level in Italian autistic childrenAutism Research, 2015
- Colonic bacterial composition in Parkinson's diseaseMovement Disorders, 2015
- Gut microbiota are related to Parkinson's disease and clinical phenotypeMovement Disorders, 2014
- DSM-5 AND ICD-11 DEFINITIONS OF POSTTRAUMATIC STRESS DISORDER: INVESTIGATING “NARROW” AND “BROAD” APPROACHESDepression and Anxiety, 2014
- Albumin is the main plasma binding protein for indoxyl sulfate and p‐cresyl sulfateBiopharmaceutics & Drug Disposition, 2013
- p-cresylsulfate and indoxyl sulfate level at different stages of chronic kidney diseaseJournal of Clinical Laboratory Analysis, 2011